MedTrace Logo

taVNS for Breast Cancer Pain and Symptom Management

NCT07500012 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-30

No results posted yet for this study

Summary

1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors.
2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in breast cancer survivors.

Conditions

  • Breast Cancer Survivors

Interventions

DEVICE

Active taVNS

practice the active taVNS twice daily for 30 minutes each over a 4-week period (56 sessions)

DEVICE

Sham taVNS

practice the sham taVNS twice daily for 30 minutes each over a 4-week period (56 sessions)

Sponsors & Collaborators

  • Florida State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-24
Primary Completion
2027-12-31
Completion
2028-02-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07500012 on ClinicalTrials.gov